Company | Group | |||||||
For the year ended 31 March | Note | Page No. | 2020 Rs. ’000 |
2019 Rs. ’000 |
Change % |
2020 Rs. ’000 |
2019 Rs. ’000 |
Change % |
Profit for the year | 2,942,508 | 4,416,121 | (33.37) | 3,591,749 | 5,011,268 | (28.33) | ||
Other comprehensive income, net of tax: | ||||||||
Items to be reclassified to profit or loss in subsequent years (net of tax): | ||||||||
Net gains/(losses) arising from translating the Financial Statements of the foreign subsidiary | 48.5 | 249 | – | – | – | 139,129 | 259,151 | (46.31) |
Net items to be reclassified to profit or loss in subsequent years | – | – | – | 139,129 | 259,151 | (46.31) | ||
Items not to be reclassified to profit or loss in subsequent years (net of tax): | ||||||||
Net actuarial gains/(losses) on defined benefit plans | ||||||||
Actuarial gains and losses on retirement benefit obligation | 44.1 | 244 | 172 | (17,909) | 100.96 | 1,225 | (20,872) | 105.87 |
Deferred tax effect on actuarial gains and losses | 43.1 | 241 | (49) | 5,670 | (100.86) | (91) | 14,028 | (100.65) |
Financial assets – Fair value through other comprehensive income | ||||||||
Gains/(losses) on re-measuring | 48.4 | 248 | (49,372) | (99,611) | 50.44 | (61,300) | (100,290) | 38.88 |
Net items not to be reclassified to profit or loss in subsequent years | (49,249) | (111,850) | 55.97 | (60,166) | (107,134) | 43.84 | ||
Other comprehensive income for the year, net of tax | (49,249) | (111,850) | 55.97 | 78,963 | 152,017 | (48.06) | ||
Total comprehensive income for the year | 2,893,259 | 4,304,271 | (32.78) | 3,670,712 | 5,163,285 | (28.91) | ||
Attributable to: | ||||||||
Equity holders of the Company | (49,249) | (111,850) | 55.97 | 82,278 | 152,757 | (46.14) | ||
Non-controlling interest | 49 | 249 | – | – | – | (3,315) | (740) | (347.97) |
Other comprehensive income for the year, net of tax | (49,249) | (111,850) | 55.97 | 78,963 | 152,017 | (48.06) | ||
Total comprehensive income for the year | 2,893,259 | 4,304,271 | (32.78) | 3,670,712 | 5,163,285 | (28.91) |
The Notes appearing on pages 155 to 288 form an integral part of the Financial Statements.